By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
    Health
    Healthcare organizations are operating on slimmer profit margins than ever. One report in August showed that they are even lower than the beginning of the…
    Show More
    Top News
    healthcare cybersecurity
    4 Helpful Tips on How to Protect Your Medical Practice Against Cyber Attacks
    October 24, 2021
    Health Check Diagnosis Medical Condition Analysis Concept
    6 Health Woes With Online Remedies
    January 19, 2022
    Eight Things Men Should Know About the Male Menopause
    Eight Things Men Should Know About the Male Menopause
    April 24, 2022
    Latest News
    6 Easy Healthcare Ways to Sit Less and Move More Every Day
    September 10, 2025
    7 Most Common Healthcare Accreditation Programs: Which Should You Use?
    August 20, 2025
    Hospital Pest Control and the Fight Against Superbugs
    August 20, 2025
    Hygiene Beyond The Clinic: Attention To Overlooked Non-Clinical Spaces
    August 13, 2025
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
    Policy and Law
    Get the latest updates about Insurance policies and Laws in the Healthcare industry for different geographical locations.
    Show More
    Top News
    pharmaphorum
    Democracy Comes to Healthcare
    May 12, 2015
    health reform
    Medical Regulations Run Amok!
    March 11, 2013
    The Risk of Concussions in Contact Sports
    September 22, 2017
    Latest News
    Healthcare at a Crossroads: Why Leadership Matters More Than Ever
    September 9, 2025
    How Social Security Disability Shapes Access to Care and Everyday Health
    August 22, 2025
    How a DUI Lawyer Can Help When Your Future Health Feels Uncertain
    August 22, 2025
    How One Fall Can Lead to a Long Road of Medical Complications
    August 22, 2025
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Theranos for President?
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Policy & Law > Medical Ethics > Theranos for President?
DiagnosticsMedical EthicsMedical InnovationsNewsPublic HealthTechnology

Theranos for President?

etwilson
etwilson
Share
5 Min Read
SHARE

In the health tech universe, function lags hype by a huge margin.

That seems to be the lesson being taught over and over again, as the promised benefits and game-changing impact of new technologies, systems, and capabilities remain as elusive as ever, even while the crowd of innovators continues to grow.

In the health tech universe, function lags hype by a huge margin.

That seems to be the lesson being taught over and over again, as the promised benefits and game-changing impact of new technologies, systems, and capabilities remain as elusive as ever, even while the crowd of innovators continues to grow.

More Read

healthcare IT
5 Questions with Dan Haley, VP of Government and Regulatory Affairs at athenahealth
ThermoGenesis to Begin Sale of Novel Stem Cell Device in India
FDA Approves Home Dialysis Machine From Fresenius Medical Care
How Big Data and the IoT Are Transforming Clinical Trial Recruitment
5 Most Valuable Healthcare Programs in 2023

Theranos (and it’s CEO Elizabeth Holmes) is, if not the latest, then certainly the largest single hype machine to slowly dissolve under scrutiny.

It is hard not to notice, in an election year, the similarities of Theranos’ trajectory and that of the typical presidential candidate. Much as America’s executive hopefuls make the usual gestures of guaranteeing change, progress, prosperity, and security, Theranos has joined the crowd of health technology innovators heralding its proprietary vision of the future as the surest way forward for everyone.

But while an overhyped presidential candidate can, at worst, be censured by the four-year term limits and election cycle, there may be no coming back from an errant diagnosis or the expense of unnecessary care. That is why it is so destructive to see that although Theranos promised to turn the blood-testing industry on its head, a series of investigative reports have shown the hype to be mostly just that: hype.

Theranos may yet prove its methods and devices and justify the great acclaim and wealth it has thus far attracted. The more important outcome in the shorter term is that compelling stories not be allowed to substitute for diligent scrutiny. Presidential elections are taxing enough; we don’t need the same sort of cult-like phenomenon driving the advance of medical science.

To a disheartening extent, a similar approach was taken—and federally endorsed—with respect to Electronic Health Records (EHR). The heralded benefit to doctors and patients, personalized care and population health, accountable care and quality tracking, all came well in advance of broadly demonstrated and duplicable outcomes. Interoperability standards came too late (in fact, they are still en route) relative to the mandated adoption of EHR platforms.

The net result is that stakeholders are both bullish and bearish when it comes to measuring progress and navigating disruption.

“It is coming faster than some people thought it would come, and slower and on a more complicated basis than others have also predicted,” explained Professor Carl Nelson in a presentation on the future of healthcare at Northeastern University.

When expectations are set according to the loudest fanfare, rather than carefully aligned with transparent, studied outcomes, the state of the industry will, paradoxically, end up showing us as being both ahead, and behind.

The spectacular potential of new technology—presented by the HITECH reforms and driving adoption alongside innovation in the HIT field—deserves continued emphasis; but it also warrants cautious skepticism.

“It’s something we may have to just live with,” Nelson concludes. “The benefits may outweigh these costs. But the trend to focus on EMRs and interoperability will continue, and should continue cautiously.”

Many an individual is crippled by healthcare costs, insurance or no. That the public, the media, and professionals across a spectrum of stakeholder industries (finance, commercial, and yes, even medical) are so readily enraptured by a good story without demanding hard data to back it up is alarming, disquieting, and ultimately, expensive both in dollars and in credibility. Populism and cults of personality may be dominant forces in American politics, but American healthcare is in the midst of a critical transition: expectations and accountability deserve to be higher.

As with Theranos, the promise of EHRs may well be delivered upon in the future; now, however, trial and error rules the day. The potential of technology must still be buttressed by the human-based systems of the past, before it can be fulfilled.

Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

a woman walking on the hallway
6 Easy Healthcare Ways to Sit Less and Move More Every Day
Health
September 9, 2025
Clinical Expertise
Healthcare at a Crossroads: Why Leadership Matters More Than Ever
Global Healthcare
September 9, 2025
travel nurse in north carolina
Balancing Speed and Scope: Choosing the Nursing Degree That Fits Your Goals
Nursing
September 1, 2025
intimacy
How to Keep Intimacy Comfortable as You Age
Relationship and Lifestyle Senior Care
September 1, 2025

You Might also Like

polio vaccine
Global HealthcareNewsPublic Health

Polio Outbreak in Europe? Disease in Middle East Imperils the Continent as Syrians Seek Refuge

November 12, 2013
Drug Seeker Or Pain Patient? Preparing Your ER For Frequent Flyers
DiagnosticseHealthHospital Administration

Drug Seeker Or Pain Patient? Preparing Your ER For Frequent Flyers

March 21, 2018
medical marijuana
eHealthMedical Innovations

Here’s How Millennials Impact Clinical Research And The Health Sector

February 25, 2019

V-Go™ Disposable No-Needle Insulin Delivery Device Receives FDA 510(k) Clearance to use Valeritas Drug

March 2, 2011
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?